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Abstract Multiple cardiac rhabdomyomas in an infant
presented with recurrent life-threatening ventricular
arrhythmias refractory to medical treatment and necessitat-
ing the placement of an implantable cardioverter defibril-
lator (ICD). The device functioned effectively as a bridge to
recovery during a 2-year follow-up period, when the tumor
showed spontaneous regression, along with an almost
complete resolution of the ventricular arrhythmias. We
conclude that childhood cardiac rhabdomyomas causing
severe drug-refractory ventricular arrhythmias can be
managed by ICD therapy.
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Introduction
Cardiac rhabdomyoma (CR) is the most common primary
cardiac tumor in childhood, with a reported incidence of
0.02 to 0.08% in live-born infants [8]. It is predominantly a
benign tumor that tends to appear between 20 and 30 weeks
gestation and regresses spontaneously in the first few years
of life [6], but is strongly associated with tuberous sclerosis,
which largely determines the long-term outcome [5]. The
natural history of CR can be complicated by hemodynamic
abnormalities, such as outflow tract obstruction, myocardial
depression, or electrical abnormalities in the form of
ventricular and supraventricular arrhythmias and conduc-
tion block [1, 9, 10]. We report a case of an infant with CR
presenting with multiple life-threatening ventricular
arrhythmias refractory to medical treatment necessitating
the placement of an implantable cardioverter defibrillator
(ICD).
Case report
A 40-day-old, previously healthy, female infant presented
with cardiac arrest due to ventricular fibrillation (VF) at
home. After successful cardiopulmonary resuscitation and
defibrillation at another hospital, she was admitted to our
hospital’s intensive care unit. She was born prematurely at
34 weeks gestational age and with a birth weight of 2,300
g. The gravidity was uneventful, hence, an antenatal
screening ultrasound was not performed in accordance with
the prenatal protocol of the Netherlands at that time. There
was no significant neonatal or family history.
The electrocardiogram on admission showed a sinus
rhythm with normal conduction intervals and severe ST
segment depression in the precordial leads (Fig. 1). The
echocardiogram revealed multiple, large tumors in both
ventricles, but predominantly in the left ventricle (Fig. 2a).
The tumors caused no inflow or outflow tract obstruction.
Since CR was suspected, a work-up for the presence of
localizations of tuberous sclerosis was performed. Magnetic
resonance imaging (MRI) of the brain and kidneys, and
dermatological and ophthalmologic assessment showed no
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abnormalities. In addition, DNA analysis for the tuberous
sclerosis (TSC2) gene was negative. Coronary angiography
confirmed the echocardiographic findings and showed
normal coronary artery anatomy without any compression.
The child experienced frequent episodes of very fast
polymorphic ventricular tachycardia (VT), with rates of more
than 300 beats per minute. There were numerous runs of non-
sustained VTs lasting several seconds to minutes and, weekly,
there were several episodes of fast sustained VT with loss of
consciousness requiring cardiac defibrillation (Fig. 3). Ven-
tricular arrhythmias were refractory to single-drug therapies,
including beta blockers, flecainide, and amiodarone. Echo-
cardiographic studies showed mild progression of the
cardiac tumors. After 3 months in hospital, in view of
refractory ventricular arrhythmias as well as tumor progres-
sion, cardiac biopsy was performed through catheterization,
which confirmed the diagnosis of rhabdomyomas.
Eventually, ventricular arrhythmias could be partially
suppressed with the combination of amiodarone (10 mg/kg)
and flecainide (6 mg/kg). In the following months, the
child’s clinical condition gradually stabilized and ICD was
first considered as a treatment option at this stage. Non-
sustained VT episodes continued, but the occurrence of
Fig. 1 Electrocardiogram on admission showing severe ST segment depression in the precordial leads
Fig. 2 Echocardiography, four-chamber view. a At presentation: the
arrows indicate large multiple tumors in the interventricular septum,
apex, and free wall of the left ventricle. b At 2.5 years of age: the
tumors have almost fully regressed. LA = left atrium, RA = right atrium,
LV = left ventricle, RV = right ventricle, IVS = interventricular septum
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sustained VT decreased. Cardiac defibrillation, however,
remained frequently necessary. At the age of 8 months, a
subcutaneous ICD system was implanted. The ICD patch
electrode was positioned subcutaneously in the left lateral
thorax, the ventricular bipolar lead epicardially on the right
ventricular apex, and the ICD generator submuscularly in
the right upper abdomen. The defibrillation threshold was
10J. After a long and stormy 7-month hospital admission,
the child was discharged home two weeks after ICD
placement. There were no ICD shocks recorded during the
period between device implant and discharge from hospital.
During 2 years of follow-up, she received three appro-
priate shocks for sustained polymorphic VT. ICD registra-
tions revealed many episodes of non-sustained VTs that
significantly decreased with time. The latest follow-up at the
age of 2.5 years showed an almost complete disappearance
of ventricular arrhythmias, correlating with near total
regression of the tumors (Fig. 2b). Her neurocognitive and
psychomotor development have been appropriate for age.
The patient still receives daily amiodarone 8 mg/kg and
flecainide 6 mg/kg, and the thyroid function remains
normal. The drug dosage has been planned for a gradual
step-down, with a possibility of the cessation of medication
in the following year. Eventually, the ICD system will be
removed if the child remains free of arrhythmias without
drug therapy.
Discussion
CR is known to regress in the postnatal period. However, in
a recently published meta-analysis on antenatally diagnosed
cases, it was shown that CR may have a high prenatal and
neonatal mortality. The size of the cardiac tumors, fetal
dysrhythmias, and hydrops were shown to be strong
predictors of poor outcome [3]. CRs may be single or
multiple, and are predominantly located in the ventricles
and interventricular septum, and less frequently in the atria.
Depending on the size and location, the tumors can also
cause inflow and outflow tract obstruction. Cardiac fibroma
is the next most common arrhythmia-inducing pediatric
cardiac tumor. However, they are almost always single and,
thus, amenable to surgical excision.
The possible electrocardiographic findings include a
variety of conduction defects, prolonged PR interval,
nonspecific ST-T wave changes, Wolff–Parkinson–White
syndrome, and aberrant intraventricular conduction, in
addition to findings of right or left ventricular hypertrophy
Fig. 3 The upper panel shows
the onset of ventricular tachy-
cardia. The lower panel is the
corresponding rhythm strip for
the episode of ventricular
tachycardia
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and right atrial enlargement. Presenting arrhythmias in CR
include supraventricular and ventricular tachycardias, as
well as bradyarrhythmias.
Ventricular arrhythmias in CR can be incessant and
difficult to control with antiarrhythmic drugs. The manage-
ment of drug-refractory ventricular arrhythmias in infancy
often requires a combination of antiarrhythmic drugs, such
as flecainide with amiodarone or sotalol [4, 11]. There
are some reports of the surgical excision of solitary
tumors that cause mechanical or electrical complications
and, at times, surgical ablation has been sought for CR
causing supraventricular tachycardia [2, 7, 14]. In the
present case, single-drug therapies failed and, subse-
quently, different antiarrhythmic drug combinations were
used. Surgical excision and ablation were not considered
in this patient due to multiple widespread tumors.
Ventricular arrhythmias were partially controlled with
high dosages of amiodarone and flecainide; however, the
risk of malignant arrhythmias and sudden cardiac death
remained significant.
This is the first reported case of CR where an ICD was
used as a successful approach to overcome life-threatening
ventricular arrhythmias in an infant. ICDs are increasingly
used in the pediatric population for both primary and
secondary prevention [12]. However, pediatric ICD therapy,
in addition to being limited by the small size of infants,
may also be associated with complications such as infection
of the device system, lead dislodgement and fracture, and a
relatively higher rate of inappropriate shocks than in adults.
In our patient, we used a novel technique for ICD
implantation in infants as reported by Stephenson et al.
[13]. The ICD generator is placed in the abdomen and a
subcutaneous finger array or patch electrode is positioned
in the left thorax. The ventricular sensing and pacing lead is
then placed epicardially or transvenously. This technique
avoids complications associated with epicardial or trans-
venous ICD systems, such as restrictive pericarditis,
thoracotomy-related issues, and venous occlusion in young
children. The subcutaneous ICD system in our patient has
proved to function very effectively during a follow-up
period of 2 years.
Conclusion
In conclusion, cardiac rhabdomyoma (CR) is a benign tumor
that regresses during the first few years of life. However, CR
can be complicated by potentially fatal ventricular arrhyth-
mias that can be difficult to suppress with antiarrhythmic
drugs. ICD therapy can act as a bridge to electrical recovery
during the course of this self-limiting disease.
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